胎児のモニタリング、診断、予知検査

出版：BCC Research（BCCリサーチ）　出版年月：2023年3月

Fetal Monitoring, Diagnostics and Predictive Tests
胎児のモニタリング、診断および予測テスト

レポート目次　　お問合せ・ご注文　　価格・納期について

Report Highlights

The global market for fetal monitoring, diagnostics and predictive tests is estimated to increase from $10.4 billion in 2022 to reach $13.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

Summary:

Worldwide, there is an increase of high-risk pregnancies that has necessitated the applications of highlevel fetal and maternal monitoring during pregnancies. Healthcare vendors are constantly developing and offering new technologies to meet the challenges posed by complicated pregnancies. In most developed countries, multiple births account for about REDACTED of all live births. Though the number of multiple births has been stabilizing in recent years, in the U.S., for every REDACTED live births, REDACTED births have been reported to be triplets.

Pregnancies have become complicated due to changes in lifestyles of women, conception after age 35 or as a teenager, obesity and diabetes in childbearing age and the success of assisted-reproduction. Physical and emotional disorders that have an impact on the health of the pregnant or postpartum individual, their baby, or both are examples of pregnancy complications. Complication-causing physical and psychological disorders can develop before, during, or after pregnancy. To reduce the risk of pregnancy difficulties, it is crucial for anybody who may become pregnant to receive medical attention before, throughout, and after pregnancy. Some of the common complications associated with
pregnancies are –

Anemia

Anemia is characterized by having fewer healthy red blood cells than is typical. Anemia patients may experience fatigue and weakness. Because the body requires more iron than usual while pregnant, pregnant people are more prone to develop iron-deficiency anemia. Throughout pregnancy, a doctor will assess the person’s red blood cell count. If at all possible, treating the underlying cause of anemia can aid in increasing the quantity of healthy red blood cells. To assist prevent and treat anemia, a doctor could also advise taking iron and/or folic acid pills.

Anxiety

Disorders of anxiety are prevalent before, during, and after pregnancy. A pregnant person may suffer with uncontrollable emotions of anxiety, uneasiness, fear, concern, and/or panic if they have an anxiety disorder. These emotions may be strong and last for a while. Additionally, the pregnant person may struggle with daily tasks like work or school as well as relationships. Depression and anxiety problems frequently coexist. It’s critical to receive therapy for anxiety before, during, and after pregnancy.

Report Scope:

This report aims to provide a comprehensive study of the global market for fetal monitoring, diagnostics, and predictive tests, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding fetal monitoring, diagnostics, and predictive tests.

An in-depth analysis of the global fetal monitoring, diagnostics and predictive tests market includes historical data and market projections on sales by application, product type, and end user. It describes the different types of fetal monitoring, diagnostics and predictive tests and their current and historical market revenues. This report also categorizes the global fetal monitoring, diagnostics and predictive tests market based on the region (North America, Europe, and Rest of the World).

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares.

Report Includes:

– 17 data tables and 54 additional tables
– Detailed overview and an up-to-date analysis of the global market for fetal monitoring, prenatal diagnostics, and predictive tests
– Analyses of the global market trends, with historic market revenue for 2019-2021, 2022, and projections of compound annual growth rates (CAGRs) through 2027
– Highlights of the current and future market potential for fetal monitoring products, diagnostic and predictive tests, along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the industry
– Estimation of the actual market size and revenue forecast for fetal monitoring and related markets in USD million values, and its corresponding market share analysis based on the product type, sample type, test type, end user, and region
– A comparative study of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers
– Updated information on the key mergers and acquisition deals, agreements, collaborations and other impactful strategies adopted by key players in the global market for fetal monitoring products, diagnostic and predictive tests
– Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
– Descriptive company profiles of the leading global players, including Abbott Laboratories, Abcam plc, Ansh Labs LLC, Beckman Coulter Inc., Contect Medical Systems Co. Ltd., and Dragerwerk AG & Co. KGaA

目次

Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 What’s New in This Update?
1.3 Scope of Report
1.4 Methodology and Information Sources
1.5 Geographic Breakdown
1.6 Analyst’s Credentials
1.7 BCC Custom Research
1.8 Related BCC Research Reports
Chapter 2 Summary and Highlights
2.1 Overview
Chapter 3 Market and Technology Background
3.1 High-Risk Pregnancies
3.1.1 Advanced Maternal Age (AMA)
3.1.2 Medical Conditions Existing Before Pregnancy
3.1.3 Medical Conditions Occurring During Pregnancy
3.1.4 Pregnancy-Related Issues
3.2 Fetal Growth Restrictions
3.3 Preterm Births
3.3.1 Global Epidemiology of Preterm Births
3.3.2 Classification of Preterm Birth
3.3.3 Preterm Birth Complications
3.3.4 Causes of Preterm Birth
3.3.5 Global Rates of Preterm Births
3.4 Oligohydramnios
3.5 Abnormal Placental Blood Flow
3.6 Meconium-Stained Liquor
3.6.1 Management of MSAF
3.7 Breech Presentation
3.7.1 Fetal Heart Rate (FHR)
3.7.2 Fetal Movement
3.7.3 Maternal Contraction
3.8 Vendors and Products for Fetal Monitoring
3.8.1 Fetoscope
3.8.2 Fetal Heart Doppler
3.8.3 Fetal Monitors
3.8.4 Fetal Scalp Electrodes
3.8.5 Telemetry
3.8.6 Fetal Pulse Oximeter
3.8.7 Fetal Ultrasound
3.8.8 Neonatal Monitoring
Chapter 4 Emerging/Upcoming Technologies in the Market
4.1 Technological Advancements in Fetal Monitoring
4.1.1 Changes in Birth Technology
4.1.2 Future of Fetal Monitoring
4.1.3 New Fetal Heart Monitoring Technologies
Chapter 5 Regulatory Structure
5.1 Regulatory Framework
5.1.1 United States
5.1.2 European Union (EU)
5.1.3 Japan
Chapter 6 Market Breakdown by Application
6.1 Market Analysis
6.2 Market Overview
6.3 Fetal Monitoring
6.3.1 Electronic Fetal Monitors
6.3.2 Fetal Dopplers
6.3.3 Other Types of Fetal Monitors
6.4 Prenatal Diagnostics
6.4.1 Fetal Ultrasound
6.4.2 Fetal MRI
6.4.3 Amniocentesis and Chorionic Villus Sampling (CVS)
6.4.4 Noninvasive cfDNA Tests
6.4.5 Preimplantation Genetic Diagnosis and Screening (PGD/PGS)
6.4.6 Other Types of Prenatal Diagnostics (Maternal Serum Screening)
6.5 Neonatal Monitoring Products
6.5.1 Essentials of Prenatal Diagnosis and Fetal Therapy
6.5.2 Prenatal Screening Tests
6.5.3 Pregnancy and Prenatal Screening Tests
6.5.4 Second Trimester Maternal Hexosaminidase Screening Test
6.5.5 Radiological Studies in Prenatal Diagnosis
6.5.6 Magnetic Resonance Imaging in Fetal Diagnosis
6.5.7 Fetal Management
6.5.8 Recent Trends Prenatal Diagnostic Tests
6.5.9 Predictive Tests Related to Pregnancy
6.5.10 Effects of Chromosomal Defects on Fetuses
6.5.11 Total Number of Predictable Carrier Genetic Diseases
6.5.12 Chance of Being a Carrier of Genetic Disease
6.5.13 Causes of Birth Defects
6.5.14 Commercially Available Genetic Tests for Carrier Screening
6.5.15 Preimplantation Genetic Testing
6.5.16 Preimplantation Genetic Diagnosis (PGD/PGS) Technologies
6.5.17 Future of PGD
Chapter 7 Impact of COVID-19 on the Market
7.1 Overview
7.1.1 Impact of COVID-19 on Fetal Monitoring, Diagnostics and Predictive Tests
7.1.2 Trade Restrictions and Supply Disruptions
Chapter 8 Competitive Landscape
8.1 Overview
8.2 Global Company Ranking
8.2.1 Other Key Players
8.3 Fetal Monitoring Industry Participants
8.3.1 Need for Innovations
8.3.2 Smart Fabric Belly Band
8.3.3 Laborview Sensor System
8.3.4 Bellabeat Interactive Monitoring Device
8.3.5 Benchtop Semiconductor Sequencing Procedure
8.3.6 Smart Sock Monitor
Chapter 9 Company Profiles
ABBOTT LABORATORIES
ABCAM PLC
AMBISEA TECHNOLOGY CORP., LTD.
ANSH LABS LLC
ATOM MEDICAL CORP.
AVIVA SYSTEMS BIOLOGY LLC
BECKMAN COULTER INC.
BERRY GENOMICS
BIONET AMERICA INC.
BISTOS Co., LTD.
CONTEC MEDICAL SYSTEMS CO. LTD.
COOPERSURGICAL INC.
CREATIVE DIAGNOSTICS
DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
DEMEDITEC DIAGNOSTICS GMBH
DRAGERWERK AG & CO.
DRE INC.
DRG INTERNATIONAL INC.
EAGLE BIOSCIENCES INC.
EDAN INSTRUMENTS INC.
ESAOTE SPA
FUKUDA DENSHI CO. LTD.
GE HEALTHCARE LTD.
GENERAL MEDITECH INC.
HITACHI MEDICAL SYSTEMS AMERICA INC.
HOLOGIC INC.
HUNTLEIGH HEALTHCARE LLC
ILLUMINA INC.
INFINIUM MEDICAL INC.
INSTITUTE OF ISOTOPES CO. LTD.
LEINCO TECHNOLOGIES INC.
LIFEWAVE BIOMEDICAL INC.
LUTECH INDUSTRIES INC.
M&B ELECTRONIC INSTRUMENTS CO. LTD.
MEDGYN PRODUCTS INC.
MEDIANA CO. LTD.
MEDICAL ECONET GMBH
MEDICHECKS LTD.
MINDCHILD MEDICAL INC.
MINDRAY MEDICAL INTERNATIONAL LTD.
MONOBIND INC.
MYRIAD GENETICS INC.
NATERA INC.
NATUS MEDICAL INC.
NEMO HEALTHCARE BV
NEOVENTA MEDICAL AB
NIHON KOHDEN CORP.
NONIN MEDICAL INC.
OB TOOLS LTD.
PENLON LTD.
PERKINELMER LIFE AND ANALYTICAL SCIENCES INC.
PHOENIX PHARMACEUTICALS INC.
PREMAITHA HEALTH LTD.
QUEST DIAGNOSTICS INC.
RAVGEN
RAYBIOTECH INC.
RESPIRONICS INC. (PHILIPS)
SEQUENOM INC.
SHENZHEN AEON TECHNOLOGY CO. LTD.
SHENZHEN COMEN MEDICAL INSTRUMENTS CO. LTD.
SHENZHEN JUMPER MEDICAL EQUIPMENT CO. LTD.
SIEMENS HEALTHCARE
SINOHERO BIOMEDICAL ELECTRONICS CO. LTD.
SMITHS MEDICAL INC.
SPACELABS HEALTHCARE INC.
TOSHIBA AMERICA MEDICAL SYSTEMS INC.
USCN LIFE SCIENCES INC.
ULTRASOUND TECHNOLOGIES LTD.
UNITED BIORESEARCH INC.
UTAH MEDICAL PRODUCTS INC.
VCOMIN TECHNOLOGY LTD.
WELCH ALLYN INC.

List of Tables
Summary Table A : Global Market for Fetal Monitoring, Diagnostics and Predictive Tests, by Application, Through 2027
Summary Table B : Global Market for Fetal Monitoring, Diagnostics and Predictive Tests, by End User, Through 2027
Table 1 : Maternal/Fetal Concerns Due to Certain Pre-Existing Maternal Conditions
Table 2 : Weight, Length, and Head Circumference, by Gestational Age
Table 3 : Weight, Length, and Head Circumference, by Gestational Age for Boys
Table 4 : Weight, Length, and Head Circumference, by Gestational Age for Girls
Table 5 : Classification of Preterm, Term and Post-Term Births
Table 6 : Survival Rates of Premature Babies
Table 7 : Long-Term Impact of Preterm Births on Survivors
Table 8 : Types of Preterm Births and Risk Factors
Table 9 : Top 20 Countries with Maximum Preterm Birth Rates
Table 10 : Gestational Age and Birthweight Characteristics, by Plurality: United States, 2020
Table 11 : Fetal Scalp Electrodes: Products and Vendors
Table 12 : Central Monitoring Stations: Products and Vendors
Table 13 : Products and Vendors of Gynecological and Obstetric Ultrasound Systems
Table 14 : Regulatory Approval: U.S. Versus Europe
Table 15 : Global Market for Fetal Monitoring, Prenatal Diagnostics and Neonatal Monitoring, by Region, Through 2027
Table 16 : Global Market for Electronic Fetal Monitors, by Region, Through 2027
Table 17 : Global Market for Fetal Monitoring by Fetal Dopplers, by Region, Through 2027
Table 18 : Global Market for Other Types of Fetal Monitoring, by Region, Through 2027
Table 19 : Global Market for Fetal Ultrasound, by Region, Through 2027
Table 20 : Global Market for Fetal MRI, by Region, Through 2027
Table 21 : Global Market for CVS, by Region, Through 2027
Table 22 : Global Market for Noninvasive cfDNA Tests, by Region, Through 2027
Table 23 : Global Market for PGD/PGS Tests, by Region, Through 2027
Table 24 : Global Market for Other Types of Prenatal Diagnostic Tests, by Region, Through 2027
Table 25 : Global Market for Neonatal Monitoring, by Region, Through 2027
Table 26 : Global Market for Predictive Genetic Tests, by Region, Through 2027
Table 27 : Prenatal Screening Tests, by Pregnancy Stage
Table 28 : Screening Test During Pregnancy
Table 29 : Selected Beta-HCG Kits and Vendors
Table 30 : Selected PAPP-A Test Kits and Vendors
Table 31 : Selected MSAFP Test Kits and Vendors
Table 32 : Selected uE3 Test Kits
Table 33 : Selected Inhibin-A Test Kits
Table 34 : Selected Maternal Hexosaminidase Test Kits
Table 35 : Second Trimester Maternal Serum Screening Analyte Patterns
Table 36 : Some Genetic Disorders That Can be Detected Before Birth
Table 37 : Prenatal Diagnostic Tests, by Pregnancy Stage
Table 38 : Five Biophysical Attributes Studied During BPP
Table 39 : Radiological Studies in Prenatal Diagnosis
Table 40 : Applications of Ultrasonography in Pregnancy
Table 41 : MRI Indications for Fetal Diagnosis When There are Ultrasound-Related Problems
Table 42 : Currently Available NGS Platform for NIPT
Table 43 : Commercially Available NGS Platform for CFDNA Tests
Table 44 : Genetic Disorders Detected, by Carrier Predictive Test
Table 45 : Leading Pharmaceuticals in Microbiome Therapeutics Partnerships
Table 46 : Chances of Being a Carrier of Genetic Disease
Table 47 : Commercially Available Genetic Tests for Carrier Screening
Table 48 : Comparison of Available PGD/PGS Technologies
Table 49 : Companies and Products for PGD Testing
Table 50 : Market Participants
Table 51 : Abbott Laboratories: Company Financials, 2021
Table 52 : Abbott Laboratories: Product Portfolio
Table 53 : Abcam plc: Company Financials, 2021
Table 54 : Abcam plc: Product Portfolio
Table 55 : Ambisea Technology Corp. Ltd.: Product Portfolio
Table 56 : Ansh Labs LLC: Product Portfolio
Table 57 : Ansh Labs LLC: Recent Developments, 2018
Table 58 : Atom Medical Corp.: Product Portfolio
Table 59 : Beckman Coulter Inc.: Product Portfolio
Table 60 : Berry Genomics: Product Portfolio
Table 61 : Bionet America Inc.: Product Portfolio
Table 62 : Bistos Co., Ltd.: Product Portfolio
Table 63 : Contect Medical Systems Co. Ltd.: Product Portfolio
Table 64 : CooperSurgical Inc.: Product Portfolio
Table 65 : Creative Diagnostics: Product Portfolio
Table 66 : Cortez Diagnostics Inc.: Product Portfolio
Table 67 : Demeditec Diagnostics: Product Portfolio
Table 68 : Dragerwerk AG & Co. KGaA: Product Portfolio
Table 69 : Clinical Data for Panorama Test
List of Figures
Summary Figure A : Global Market for Fetal Monitoring, Diagnostics and Predictive Tests, by Application, 2019-2027
Summary Figure B : Global Market for Fetal Monitoring, Diagnostics and Predictive Tests, by End User, 2019-2027
Figure 1 : Distribution of Small Fetuses Due to Fatal Growth Restrictions
Figure 2 : Risk Factors for Neonatal and Post Neonatal Deaths
Figure 3 : Global Market for Fetal Monitoring, Prenatal Diagnostics and Neonatal Monitoring, by Region, 2019-2027
Figure 4 : Global Market for Electronic Fetal Monitors, by Region, 2019-2027
Figure 5 : Global Market for Fetal Monitoring by Fetal Dopplers, by Region, 2019-2027
Figure 6 : Global Market for Other Types of Fetal Monitoring, by Region, 2019-2027
Figure 7 : Global Market for Fetal Ultrasound, by Region, 2019-2027
Figure 8 : Global Market for Fetal MRI, by Region, 2019-2027
Figure 9 : Global Market for CVS, by Region, 2019-2027
Figure 10 : Global Market for Noninvasive cfDNA Tests, by Region, 2019-2027
Figure 11 : Global Market for PGD/PGS Tests, by Region, 2019-2027
Figure 12 : Global Market for Other Types of Prenatal Diagnostic Tests, by Region, 2019-2027
Figure 13 : Global Market for Neonatal Monitoring, by Region, 2019-2027
Figure 14 : Causes of Fetal Abnormalities
Figure 15 : Abbott Laboratories: Revenue Share, by Business Segment, 2021
Figure 16 : Abbott Laboratories: Revenue Share, by Region, 2021